Efficacy and Safety of Auto-FMT in Preventing aGVHD
Efficacy and Safety of Autologous Fecal Bacteria Transplantation in Preventing Acute Graft Versus Host Disease After Haploidentical Hematopoietic Stem Cell Transplantation: a Multicenter, Open, Randomized Controlled Clinical Study
The First Affiliated Hospital of Soochow University
100 participants
Mar 1, 2021
INTERVENTIONAL
Conditions
Summary
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
Eligibility
Inclusion Criteria1
- Haplo-HSCT patients; Bacteroidetes >0.1%; inverse Simpson diversity ≥2
Exclusion Criteria1
- Gastrointestinal diseases；Age>60; or Age<10；Probiotics or prebiotics were taken before enrollment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
autologous fecal bacteria transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04745221